Dr. Siekmeier is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
115 Mill St
Belmont, MA 02478Phone+1 617-855-3588Fax+1 617-855-3789
Education & Training
- Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1997 - 2001
- Yale School of MedicineClass of 1997
- Massachusetts Institute of TechnologyMS, 1993
Certifications & Licensure
- MA State Medical License 1999 - 2026
- American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- Travel Award American College of Neuropsychopharmacology, 2012
Publications & Presentations
PubMed
- 139 citationsModeling GABA Alterations in Schizophrenia: A Link Between Impaired Inhibition and Altered Gamma and Beta Range Auditory EntrainmentDorea Vierling-Claassen, Peter J. Siekmeier, Steven M. Stufflebeam, Nancy Kopell
Journal of Neurophysiology. 2008-02-20 - 7 citationsComputational modeling of psychiatric illnesses via well-defined neurophysiological and neurocognitive biomarkers.Peter J. Siekmeier
Neuroscience and Biobehavioral Reviews. 2015-10-01 - 15 citationsDevelopment of Antipsychotic Medications with Novel Mechanisms of Action Based on Computational Modeling of Hippocampal NeuropathologyPeter J. Siekmeier, David P. vanMaanen
Plos One. 2013-03-19
Abstracts/Posters
- Increased beta-gamma power ratio in MEG auditory steady-state responses: A potential biomarker for chronic schizophreniaSiekmeier, P.J., Stufflebeam, S.M., Spencer, S.K., Hamalainen, M., McCarley, R., Neuropsychopharmacology, 12/10/2014
- Treatment of dopaminergic dysfunction in schizophrenia using non-dopaminergic mechanisms: A computational modeling approachSiekmeier, P.J. and vanMaanen, D.P., Neuropsychopharmacology, 12/9/2013
- Novel EEG biomarkers for the a priori identification of responders to the experimental antipsychotic agen pomaglumetad methionilSiekmeier, P.J. and Lowen, S.B., Neuropsychopharmacology, Florida, 12/11/2019
- Join now to see all
Other
- Apparatuses and methods for identification and treatment of patients responsive to antipsychotic agent therapy. WO Patent Application No. PCT/US2020/49194.P. J. Siekmeier, S.B. Lowen, and J.T. Coyle
https://patentimages.storage.googleapis.com/eb/a4/a9/7fbc05f4a335c2/WO2021046215A1.pdf
9/3/2020 - Method of increasing cognitive function with glutamate receptor agonist. WO Patent Application No. PCT/US2020/49283.P. Siekmeier, S. Lowen, and J.T. Coyle.
https://patentimages.storage.googleapis.com/d0/97/bc/3b8faf78d14b41/WO2021046273A1.pdf
9/3/2020 - Systems and methods for modeling and predicting effective treatments for schizophrenia and other disorders. U.S. Patent No. 10,720,242.P. Siekmeier, McLean Hospital assignee
https://patentimages.storage.googleapis.com/60/b7/7c/a9d737b20ebfbe/US10720242.pdf
7/21/2020 - Join now to see all
Press Mentions
- FarewellMay 8th, 2017
- Recent patent applications in drug screeningSeptember 28th, 2021
- Long-time interest in biorhythms settles into fascination with oscillations in cognitionOctober 21st, 2021
Grant Support
- Computational Modeling Of Hippocampus In SchizophreniaNational Institute Of Mental Health2007–2011
- The Use of a Neurocomputational Model to Examine the Hippocampal Etiologies of Schizophrenia and Develop More Effective Pharmacologic TreatmentsNational Alliance for Research on Schizophrenia and Depression (NARSAD)2004–2006
- Use of a Computational Model of Hippocampus Subfield CA1 to Examine the Neuropathology of SchizophreniaNational Alliance for Research on Schizophrenia and Depression (NARSAD)2002–2004
Professional Memberships
- Member
- Society of Biological PsychiatryMember
External Links
- McLean Hospitalhttp://www.mcleanhospital.org/biography/peter-siekmeier
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: